Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.244ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.244ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.244ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.244NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
JD.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.17.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.17.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.17.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.17.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.7.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.7.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.7.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.7.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.10.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.10.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.10.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.10.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KG.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KG.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KG.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KG.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HA.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HA.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.351 (Beta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.351 (Beta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used